Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma

por Yang, Yonghao, Li, Jun, Till, Brian G., Wang, Jun, Zhang, Bicheng, Wang, Hanping, Huang, Hao, Li, Tiepeng, Gao, Quanli, Li, Hongle, Wang, Zibing
Publicado 2021

Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma

por Greenbaum, Adam M., Green, Damian J., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Rasmussen, Heather, Press, Oliver W., Gopal, Ajay K.
Publicado 2018

Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

por Budde, Lihua E., Berger, Carolina, Lin, Yukang, Wang, Jinjuan, Lin, Xubin, Frayo, Shani E., Brouns, Shaunda A., Spencer, David M., Till, Brian G., Jensen, Michael C., Riddell, Stanley R., Press, Oliver W.
Publicado 2013

CD8(+) chimeric antigen receptor T cells manufactured in absence of CD4(+) cells exhibit hypofunctional phenotype

por Lee, Sang Yun, Lee, Dong Hoon, Sun, Wei, Cervantes-Contreras, Francisco, Basom, Ryan S, Wu, Feinan, Liu, Si, Rai, Richa, Mirzaei, Hamid R, O’Steen, Shyril, Green, Damian J, Shadman, Mazyar, Till, Brian G
Publicado 2023

Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma

por Green, Damian J., Bensinger, William I., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Pagel, John M., Frayo, Shani L., Roden, Jennifer E., Hedin, Lacey, Press, Oliver W., Gopal, Ajay K.
Publicado 2016

Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies

por Huang, Hao, Peng, Ling, Zhang, Bicheng, Till, Brian G., Yang, Yonghao, Zhang, Xiaojie, Zhao, Lingdi, Fu, Xiaomin, Li, Tiepeng, Han, Lu, Qin, Peng, Chen, Lin, Yan, Xiang, Liu, Yang, Wang, Wenkang, Ye, Zhenlong, Li, Hongle, Gao, Quanli, Wang, Zibing
Publicado 2022

Predictors of response to axicabtagene‐ciloleucel CAR T cells in aggressive B cell lymphomas: A real‐world study

por Iovino, Lorenzo, Wu, Qian Vicky, Voutsinas, Jenna, Panaite, Lorena, Mullane, Erin, Lynch, Ryan C., Ujjani, Chaitra, Smith, Stephen D., Gopal, Ajay K., Till, Brian G., Milano, Filippo, Chow, Victor, Gauthier, Jordan, Turtle, Cameron J., Maloney, David G., Shadman, Mazyar
Publicado 2022

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

por Liang, Emily C., Albittar, Aya, Huang, Jennifer J., Hirayama, Alexandre V., Kimble, Erik L., Portuguese, Andrew J., Chapuis, Aude, Shadman, Mazyar, Till, Brian G., Cassaday, Ryan D., Milano, Filippo, Kiem, Hans-Peter, Riddell, Stanley R., Turtle, Cameron J., Maloney, David G., Gauthier, Jordan
Publicado 2023

The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up

por Ujjani, Chaitra S., Poh, Christina, Tu, Brian, Lee, Sydney, Selke, Stacy, Zhu, Haiying, Shadman, Mazyar, Lynch, Ryan C., Huang, Meei-Li W, Gopal, Ajay K., Warren, Edus H., Till, Brian G., Smith, Stephen D, Sperling, Amy, Hill, Joshua A., Stevenson, Philip, Nielsen, Leslie, Gooley, Ted A., Greninger, Alexander L
Publicado 2022